C149 - What Do I Do Now?: Neurologic Consultations in Cancer Patients I

Event Time: Wednesday April 25, 2018 1:00 pm to 3:00 pm
Topic(s): Neuro-oncology
Director(s): Amy Pruitt MD, FAAN
Description: Faculty will present an overview of the evolving spectrum of neurologic complications of immunotherapies and then, using audience response system, discuss 10-12 cases representing such problems as stroke in a cancer patient, complications of new immune checkpoint inhibitors, acute mental status changes in transplant recipients, and neurologic problems of cancer survivors such as chemobrain, secondary neoplasms, and infections. Some cases will address the evolving role of palliative care consultation in the management of these patients. This program complements C164: What Do I Do Now?: Neurologic Consultations in Cancer Patients II, but covers independent topics.
Completion Message: Participants should be able to recognize the complications of PD-1 and CTLA-4 inhibitors and to manage thromboembolic complications in cancer patients. They will also recognize toxicities of drugs used in transplantation, efficiently evaluate patients for CNS infections, and screen for neurologic treatment sequelae in long-term cancer survivors.
CME Credits: 2
Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care

Ready to register for the 2019 AAN Annual Meeting?

Register Now

Related Courses